Annovis Bio, Inc.
Annovis Bio, Inc. scores highest on Earnings (46) and lowest on Price (0). Its PosiPenta is 29.67 out of 100, weaker than most similar companies.
On the Penta Grid this week, Annovis Bio, Inc. is Grid #763 of 837 in the Healthcare sector in United States, and Grid #3,631 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Annovis Bio, Inc. | 29.67 | 0 | 46 | 11 | 46 | 45 |
| Biomea Fusion, Inc. | 30.01 | 13 | 36 | 32 | 37 | 33 |
| INmune Bio Inc. | 47.03 | 27 | 52 | 60 | 46 | 50 |
| Xtant Medical Holdings, Inc. | 42.88 | 39 | 69 | 25 | 45 | 36 |
| Tevogen Bio Holdings Inc. | 40.50 | 0 | 12 | 28 | 96 | 67 |
| Hyperion DeFi, Inc. | 37.74 | 47 | 12 | 31 | 68 | 32 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.57 |
| P/B ratio | -9.96 |
EEarnings
| Trailing EPS | ₹-165.75 |
| Forward EPS | ₹-81.45 |
NNitro
| Price | 94.09 |
| 52-week high | 520.93 |
| 52-week low | 93.48 |
| Fall from 52-week high | 81.9% |
TTorque
| Return on equity (ROE) | -703.68% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 1.23 |
| Market cap | ₹401 Cr |
| Insider holding | 11.79% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Annovis Bio, Inc.'s PosiPenta score?
Annovis Bio, Inc.'s PosiPenta is 29.67 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Annovis Bio, Inc. stand on the Penta Grid?
On the Penta Grid this week, Annovis Bio, Inc. is Grid #763 of 837 in the Healthcare sector in United States, and Grid #3,631 of 4,000 in United States.
Which PosiPenta pillar is strongest for Annovis Bio, Inc.?
Earnings (growth), with a score of 46 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Annovis Bio, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Annovis Bio, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.63 points, from 27.04 to 29.67.
PositoAI is for research and education only and is not investment advice.